Milton Hall Primary School Remote Learning Plan
In order to ensure that learning is continued, irrespective of lockdown and self-isolation, Milton Hall Primary School has developed the following plan. This plan offers remote learning opportunities whilst also acknowledging that some households have limited access to devices and would require hard-copies of work and resources.
This plan will be applied in the following instances:
1. An individual is self-isolating because of a positive test within the household;
2. A group of children are self-isolating because of a case of coronavirus in the bubble;3. A whole bubble or cohort is self-isolating because of an outbreak of coronavirus
Coronavirus (COVID-19) universal catch-up premium
In June, a £1 billion fund for education was announced by the government. Further guidance has now been released (https://www.gov.uk/guidance/coronavirus-covid-19-catch-up-premium) showing that the money is split between a catch-up premium and a national tutoring scheme.
The catch-up premium will be calculated on a per pupil basis, providing each mainstream school with a total of £80 for each pupil in years reception through to year 6. This will be paid in 3 instalments - in autumn 2020, 'early 2021' and summer 2021. The school will receive a total of £46.67 per pupil split across payments 1 and 2 and £33.33 per pupil for payment 3.
As the catch-up premium has been designed to mitigate the effects of the unique disruption caused by coronavirus (COVID-19), the grant will only be available for the 2020 to 2021 academic year. It will not be added to schools’ baselines in calculating future years’ funding allocations.
Schools have the flexibility to spend their funding in the best way for their cohort and circumstances. Accountability and monitoring as with all government funding, school leaders must be able to account for how this money is being used to achieve our central goal of schools getting back on track and teaching a normal curriculum as quickly as possible. Given their role in ensuring schools spend funding appropriately and in holding schools to account for educational performance, governors and trustees should scrutinise schools’ approaches to catch-up from September, including their plans for and use of catch-up funding. This should include consideration of whether schools are spending this funding in line with their catch-up priorities, and ensuring appropriate transparency for parents. (DfE guidance - Coronavirus (COVID-19) catch-up premium - updated 24/08/2020)
“Children from disadvantaged backgrounds are likely to have been more affected particularly severely by closures and may need more support to return to school and settle back into school life. Whilst all pupils will benefit from the EEF recommendations, it is likely that some forms of support will be particularly beneficial to disadvantaged.”
(Covid-19 Support Guide for Schools – June 2020)
Please see the following link for the latest guidance from Public Health England:
In light of the coronavirus outbreak (COVID-19) we would appreciate it if you would inform us if you are planning a trip overseas, even if it’s during school holidays. Please can you inform the school office of the dates you intend to travel and the destination. You can do this by emailing the office at firstname.lastname@example.org, via the school app or in person at the school office.
We would also like to inform you that The Department for Education has launched a new helpline to answer questions about COVID-19 related to education. Parents and young people can contact the helpline as follows:
The opening hours are 8am to 6pm (Monday to Friday).
To view Mr. Buxton's washing hands song please click this link https://youtu.be/gdnduJRGFbs
What we know about the virus and the diseases it causes Coronaviruses are a family of viruses common across the world in animals and humans; certain types cause illnesses in people. For example, some coronaviruses cause the common cold; others cause diseases which are much more severe such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), both of which often lead to pneumonia.
COVID-19 is the illness seen in people infected with a new strain of coronavirus not previously seen in humans. On 31st December 2019, Chinese authorities notified the World Health Organisation (WHO) of an outbreak of pneumonia in Wuhan City, which was later classified as a new disease: COVID-19.
On 30th January 2020, WHO declared the outbreak of COVID-19 a “Public Health Emergency of International Concern” (PHEIC).
Based on current evidence, the main symptoms of COVID-19 are a cough, a high temperature and, in severe cases, shortness of breath.
As it is a new virus, the lack of immunity in the population (and the absence as yet of an effective vaccine) means that COVID-19 has the potential to spread extensively. The current data seem to show that we are all susceptible to catching this disease, and thus it also more likely than not that the UK will be significantly affected. Among those who become infected, some will exhibit no symptoms. Early data suggest that of those who develop an illness, the great majority will have a mild-to-moderate, but self-limiting illness – similar to seasonal flu.
It is, however, also clear that a minority of people who get COVID-19 will develop complications severe enough to require hospital care, most often pneumonia. In a small proportion of these, the illness may be severe enough to lead to death.
So far the data has suggested that the risk of severe disease and death increases amongst elderly people and in people with underlying health risk conditions (in the same way as for seasonal flu). Illness is less common and usually less severe in younger adults. Children can be infected and can have a severe illness, but based on current data overall illness seems rarer in people under 20 years of age. So far, there has been no obvious sign that pregnant women are more likely to be seriously affected.
Work is in hand to contain the spread of the virus. This includes extensive guidance provided to individuals returning from areas where there are cases being reported, and encouraging self-isolation as the primary means to contain the spread of the disease. Given that there is currently neither a vaccine against COVID-19 nor any specific, proven, antiviral medication, most treatment will therefore be towards managing symptoms and providing support to patients with complications. The majority of people with COVID-19 have recovered without the need for any specific treatment, as is the case for the common cold or seasonal flu - and we expect that the vast majority of cases will best be managed at home, again as with seasonal colds and flu.